Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3001334	s-ancak	— (—)	247	259	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Bacterial infection, other or unspecified

9.65

64.82

1.1

1.0

—

Bacterial infection, other or unspecified

9.24

64.35

1.1

1.0

—

Dialysis, with operation codes

22.08

62.30

1.0

1.1

—

Acute renal failure

14.07

61.25

1.1

—

Renal failure

8.27

59.80

1.0

1.1

—

Renal tubulo-interstitial diseases

106

121

6.53

57.97

1.0

—

Other bacterial diseases

109

111

6.61

57.35

1.1

1.0

—

All kidney diseases

111

120

6.33

56.71

1.0

1.1

—

Other bacterial diseases

111

109

6.47

55.75

1.1

1.0

—

ILD medications: immunosuppressive drugs

7.82

55.74

1.1

1.0

—

All chronic kidney diseases

8.09

55.31

1.0

1.1

—

Nephropathy related operations

18.48

55.17

1.0

—

Bacterial Sepsis

8.19

46.51

1.1

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

106

100

5.93

46.44

1.1

1.0

—

Chronic kidney disease

9.18

45.95

1.1

—

Implicit Sepsis

105

6.11

44.10

1.1

1.0

—

Pneumonia, organism unspecified

116

5.69

44.08

1.1

1.0

—

ILD medications

107

103

5.64

44.08

1.1

1.0

—

Implicit bacterial Sepsis

7.98

43.56

1.1

1.0

—

Septicaemia

8.24

42.84

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

128

5.28

42.63

1.1

1.0

—

Influenza and pneumonia

102

123

5.28

42.57

1.1

1.0

—

Other septicaemia

8.96

42.33

1.1

1.0

—

Implicit bacterial Sepsis

7.78

42.14

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5.81

42.08

1.1

1.0

—

5.81

42.08

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

127

5.24

42.01

1.1

1.0

—

All pneumoniae

127

5.21

41.73

1.1

1.0

—

Implicit Sepsis

112

5.68

41.56

1.1

1.0

—

Explicit Sepsis

7.67

41.08

1.1

1.0

—

Systemic connective tissue disorders

7.81

38.64

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

112

5.36

37.78

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

141

4.70

36.73

1.0

—

Oral corticosteroids

122

4.82

36.54

1.1

1.0

—

Fever of other and unknown origin

6.00

35.05

1.1

1.0

—

First line medication for Crohn's disease

104

4.94

34.51

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

113

5.07

34.50

1.1

1.0

—

Inflammatory bowel disease treatment related agents

126

4.31

30.90

1.1

1.0

—

Glomerular diseases

9.29

30.89

1.1

—

Heart failure, not strict

106

4.62

26.95

1.1

—

L04AA Selective immunosuppressants

7.37

24.98

1.1

1.0

—

Heart failure,strict

5.14

23.95

1.1

—

Bacterial pneumoniae

6.15

21.85

1.1

1.0

—

Autoimmune diseases related-to ILD

161

3.72

21.69

1.1

1.0

—

Bacterial pneumonia, not elsewhere classified

5.98

20.74

1.1

1.0

—

Any death

4.39

20.65

1.1

—

Other necrotizing vasculopathies

22.52

20.36

1.1

—

Other respiratory diseases principally affecting the interstitium

7.59

19.93

1.1

—

Continuous positive airway pressure

9.14

19.74

1.1

1.0

—

Heart failure, strict

4.14

19.44

1.1

—

Heart failure and antihypertensive medication

9.05

19.12

1.0

1.1

—

Polyarthropathies

106

3.89

18.98

1.1

1.0

—

L04AX Other immunosuppressants

125

4.08

18.82

1.1

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

9.36

18.78

1.0

1.1

—

Persons encountering health services for specific procedures and health care

144

3.25

17.77

1.0

1.1

—

Reimbursement for rheumatic diseases

122

4.00

17.62

1.0

1.1

—

Second line medication for Crohn's disease

132

3.87

17.50

1.1

1.0

—

Certain infectious and parasitic diseases

3.90

17.18

1.0

—

Other necrotizing vasculopathies (FG)

22.02

16.85

1.1

1.0

—

Implicit viral Sepsis

6.05

16.81

1.0

—

Dyspnoea

158

3.23

16.68

1.1

1.0

—

Ulcer of lower limb, not elsewhere classified

7.30

16.51

1.1

1.0

—

All-cause Heart Failure

3.86

16.33

1.0

1.1

—

L04AD Calcineurin inhibitors

14.29

16.28

1.1

1.0

—

Gout

5.39

16.23

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

110

3.70

16.22

1.0

1.1

—

COPD/asthma related infections

3.48

16.01

1.1

1.0

—

COPD/asthma/ILD related infections

3.48

16.01

1.1

1.0

—

Gout, FINNGEN

5.07

15.89

1.0

—

Bacterial pneumonia (organism specified)

4.11

15.60

1.1

1.0

—

Care involving dialysis

19.29

15.53

1.1

—

Erysipelas

4.04

15.45

1.1

1.0

—

Other systemic involvement of connective tissue (FG)

5.93

15.28

1.1

1.0

—

ILD, hospital admissions

6.99

15.24

1.1

1.0

—

Other interstitial pulmonary diseases

6.99

15.24

1.1

1.0

—

Interstitial lung disease endpoints

6.79

14.84

1.1

1.0

—

Interstitial lung disease

6.79

14.84

1.1

1.0

—

Other disorders of urethra and urinary system

109

3.51

14.48

1.1

—

Hypertensive diseases (excluding secondary)

5.64

14.28

1.0

1.1

—

Glomerular disorders in diseases classified elsewhere

11.36

14.25

1.0

—

Acute tubulo-interstitial nephritis

101

3.76

14.01

1.0

—

Unspecified kidney failure

14.73

13.55

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

133

2.92

13.38

1.1

1.0

—

Extracorporeal dialysis

18.32

13.36

1.1

1.0

—

Gout, idiopatic and unspecified

4.84

13.29

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

137

2.87

13.13

1.1

1.0

—

Other systemic involvement of connective tissue

5.10

13.13

1.1

1.0

—

Transplanted organ and tissue status

11.55

12.78

1.0

1.1

—

Other heart diseases

5.26

12.41

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

4.34

12.26

1.0

—

Heart failure and coronary heart disease

3.90

12.25

1.1

1.0

—

Aplastic and other anaemias

104

3.59

12.21

1.0

1.1

—

Gout, unspecified

4.92

12.13

1.0

1.1

—

ILD, hospital admission 2, with pulmonary infections

12.41

12.10

1.1

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

13.02

11.89

1.1

1.0

—

General symptoms and signs

112

2.91

11.82

1.1

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

142

3.09

11.75

1.1

1.0

—

Abnormalities of breathing

106

3.07

11.71

1.1

1.0

—

COPD (mode)

5.31

11.66

1.0

—

DVT of lower extremities and pulmonary embolism

3.66

11.54

1.1

—

ILD, hospital admissions 3, with pneumonia sepsis

11.11

11.52

1.1

1.0

—

Malaise and fatigue

3.81

11.49

1.0

—

Cerebrovascular diseases (FINNGEN)

6.46

11.25

1.1

1.0

—

Haemorrhage from respiratory passages

4.29

11.17

1.1

1.0

—

Cardiomyopathy

5.54

11.15

1.0

1.1

—

Finngen Rheumatological endpoints

116

2.89

11.14

1.1

1.0

—

Kidney transplant status

20.14

11.13

1.1

1.0

—

Venous thromboembolism

127

3.20

10.88

1.1

1.0

—

ILD medications: azathioprine

11.20

10.53

1.3

1.0

—

Bleeding

148

2.74

10.49

1.1

1.0

—

Gout, strict definition

4.80

10.46

1.0

1.1

—

Erysipelas

3.63

10.43

1.1

1.0

—

Azathioprine

10.58

10.25

1.3

1.0

—

Antihypertensive medication - note that there are other indications

4.17

10.12

1.0

1.1

—

Other diseases of pleura

111

3.16

9.96

1.1

1.0

—

Heart failure and bmi 25plus

4.06

9.81

1.1

—

Later onset COPD, excluding more controls

5.88

9.72

1.1

1.0

—

Anaemias

10.05

9.54

1.0

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

4.78

9.52

1.0

—

Peripheral artery disease

3.34

9.51

1.0

1.1

—

ILD, hospital admissions 1, main diag only

7.52

9.39

1.1

1.0

—

Autoimmune diseases

137

2.49

9.33

1.1

1.0

—

Cardiovascular diseases

3.86

9.31

1.0

—

Abnormal findings on diagnostic imaging of lung

119

3.06

9.21

1.1

1.0

—

Other acute lower respiratory infections

124

3.00

9.11

1.2

1.0

—

Peripheral arterial reconstruction

4.57

9.04

1.0

1.1

—

Care involving use of rehabilitation procedures

126

2.92

8.86

1.0

1.1

—

Pain in throat and chest

103

2.80

8.80

1.1

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

3.29

8.79

1.0

1.1

—

Glomerulonephritis

8.60

8.78

1.1

1.0

—

Valvular heart disease excluding rheumatic fever

3.36

8.58

1.0

1.1

—

Non-rheumatic valve diseases

3.36

8.57

1.0

1.1

—

Other diseases of urinary system

133

2.49

8.56

1.0

1.1

—

Infections of the skin and subcutaneous tissue

151

2.76

8.53

1.1

—

Rheumatoid arthritis

3.87

8.47

1.0

1.1

—

Other arthritis (FG)

4.08

8.24

1.2

1.0

—

Complications of procedures, not elsewhere classified

169

2.50

8.23

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

174

2.36

8.23

1.0

1.1

—

Other and unspecified iron deficiency

3.42

8.18

1.1

—

Asthma, unspecified (mode), excluding more controls

3.90

8.09

1.1

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

3.38

8.04

1.1

—

Peripheral artery operations in Hilmo

6.80

8.04

1.0

1.1

—

Non-ischemic cardiomyopathy

3.80

8.01

1.0

1.1

—

Diabetic nephropathy

4.69

7.95

1.1

—

Iron deficiency anaemia

3.12

7.84

1.1

—

Caries of dentine

3.80

7.78

1.0

1.1

—

Nutritional anaemias

117

2.89

7.71

1.1

1.0

—

Dental caries

3.67

7.71

1.0

1.1

—

Tramadol

111

2.60

7.64

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

3.33

7.63

1.1

1.0

—

Exposure to unspecified factor

187

2.27

7.54

1.1

1.0

—

Codeine or tramadol medication

162

2.23

7.53

1.1

1.0

—

Codeine

120

2.45

7.51

1.1

—

Other and unspecified anaemias

102

2.99

7.50

1.0

1.1

—

Other anaemias

102

2.98

7.46

1.0

1.1

—

Speech therapy

3.53

7.40

1.0

1.1

—

Any gastric operation

2.81

7.36

1.0

—

GASTRO-related operations

2.81

7.36

1.0

—

Implicit viral Sepsis

5.95

7.36

1.0

—

Viral Sepsis

5.95

7.36

1.0

—

Pulmonary embolism

3.34

7.35

1.1

—

Pulmonary heart disease

3.34

7.35

1.1

—

Examination and observation for other reasons

2.76

7.31

1.0

—

Infections, IBD-co-morbidities

7.60

7.27

1.0

—

Acute bronchitis

3.03

7.26

1.1

1.0

—

Asthma-related pneumonia

3.14

7.21

1.1

1.0

—

Asthma, hospital admissions 3, pneumonia

3.14

7.21

1.1

1.0

—

Asthma-related pneumonia or sepsis

3.14

7.21

1.1

1.0

—

Complications of medical and surgical care

169

2.45

7.18

1.0

—

Hypertension, essential

2.73

6.96

1.0

1.1

—

Hypertensive diseases

2.69

6.95

1.0

1.1

—

Diabetic nephropathy, excluding more controls

6.18

6.95

1.1

—

Hypertension

2.69

6.95

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

2.72

6.92

1.1

1.0

—

COPD

2.84

6.85

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

2.84

6.81

1.1

1.0

—

Other pulmonary diagnosis

2.84

6.81

1.1

1.0

—

Polymyalgia rheumatica

6.68

6.80

1.1

1.0

—

Disorders resulting from impaired renal tubular function

16.78

6.75

1.0

—

Cutaneous abscess, furuncle and carbuncle

3.62

6.73

1.1

1.0

—

Certain infectious and parasitic diseases

2.85

6.68

1.1

1.0

—

Used for control exclusion in common control thyroid runs

127

2.27

6.65

1.1

1.0

—

COPD differential diagnosis

2.80

6.65

1.1

1.0

—

ILD differential diagnosis

2.80

6.65

1.1

1.0

—

Cardiomyopathies, Primary/intrinsic

6.42

6.62

1.1

—

Asthma

2.82

6.48

1.1

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

150

2.50

6.47

1.0

—

Cardiomyopathy (excluding other)

6.17

6.45

1.1

—

Atrial fibrillation and flutter

4.60

6.38

1.0

1.1

—

Giant cell arteritis

11.07

6.30

1.1

—

Dilated cardiomyopathy

5.94

6.29

1.1

1.0

—

Protozoal diseases

18.13

6.27

1.2

1.0

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

18.13

6.27

1.0

—

Myocardial infarction

2.80

6.04

1.1

1.0

—

Asthma, unspecified (mode)

3.14

6.02

1.1

1.0

—

Other disorders of skin and subcutaneous tissue

155

2.35

6.01

1.1

1.0

—

Asthma, excluding more controls

2.94

6.00

1.1

1.0

—

Other chronic obstructive pulmonary disease

2.72

5.99

1.1

1.0

—

154

2.08

5.99

1.1

1.0

—

Paroxysmal tachycardia

6.28

5.98

1.0

1.1

—

Other diseases of the respiratory system

3.68

5.91

1.2

1.1

—

Other respiratory disorders and diseases

3.68

5.91

1.2

1.1

—

Pericarditis

15.08

5.90

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

107

2.29

5.90

1.0

—

Intestinal infectious diseases

190

2.12

5.88

1.1

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

159

2.32

5.88

1.1

—

Liquid cancers, helper endpoint

2.95

5.87

1.0

1.1

—

Seropositive rheumatoid arthritis

3.66

5.87

1.1

1.0

—

Other diseases of blood and blood-forming organs, wide

3.52

5.87

1.1

1.0

—

Opioids

122

2.21

5.85

1.1

1.0

—

Enterocolitis due to Clostridium difficile

6.38

5.85

1.0

—

Major coronary heart disease event

121

2.29

5.85

1.1

1.0

—

Asthma (only as main-diagnosis)

2.76

5.79

1.1

1.0

—

Rheumatoid arthritis, including avohilmo

2.86

5.76

1.0

—

Emergency coronary revascularization (for ACS)

127

2.25

5.74

1.1

1.0

—

Other disorders of kidney and ureter

6.10

5.68

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

3.19

5.63

1.1

—

Asthma, hospital admission 2, infections

148

2.38

5.56

1.1

1.0

—

Asthma-related infections

148

2.38

5.56

1.1

1.0

—

Other heart diseases, wide

122

2.26

5.54

1.0

—

Certain disorders involving the immune mechanism

3.81

5.53

1.0

—

Cough

3.06

5.42

1.2

1.0

—

Coronary revascularization (ANGIO or CABG)

112

2.30

5.40

1.1

1.0

—

Pain in limb

141

2.18

5.38

1.0

1.1

—

Other disorders involving the immune mechanism, not elsewhere classified

11.32

5.29

1.0

—

Implicit fungal Sepsis

9.12

5.28

1.0

—

Ischemic heart diseases

119

2.22

5.23

1.0

—

Microscopic polyangiitis

+∞

5.23

1.0

0.0

—

Amputation

5.40

5.21

1.0

—

ILD-related respiratory insufficiency

13.41

5.08

1.1

1.0

—

Temporal arteritis

13.40

5.08

1.1

1.0

—

Diseases of the skin and subcutaneous tissue

122

2.10

5.05

1.1

1.0

—

Percutaneous Coronary Intervention

112

2.24

5.03

1.1

1.0

—

COPD, early/later onset

106

2.47

5.03

1.1

1.0

—

Hard cardiovascular diseases

113

2.22

4.98

1.0

—

Cellulitis

3.34

4.87

1.0

—

Streptococcal septicaemia

7.71

4.84

1.1

1.0

—

Asthma (mode)

2.52

4.82

1.1

1.0

—

Myocardial infarction, strict

2.59

4.82

1.1

1.0

—

Methotrexate

6.48

4.76

1.1

1.0

—

Cystitis

115

2.17

4.76

1.0

1.1

—

All influenza

3.57

4.75

1.1

1.0

—

Sulfasalazine

3.41

4.74

1.1

1.0

—

STROKE

2.57

4.71

1.1

1.0

—

Other soft tissue disorders, not elsewhere classified

146

2.01

4.64

1.0

1.1

—

Purpura and other haemorrhagic conditions

5.01

4.62

1.0

—

Pneumocystosis

14.13

4.58

1.3

1.0

—

Giant cell arteritis with polymyalgia rheumatica

10.05

4.52

1.1

1.0

—

Cardiodefibrillation

104

2.50

4.50

1.0

1.1

—

COPD, hospital admission 2, with asthma infections

2.70

4.50

1.1

—

Cardiomyopathy, other and unspecified

6.68

4.46

1.0

1.1

—

Type 2 diabetes, wide definition

133

2.07

4.43

1.0

1.1

—

Other specific joint derangements/joint disorders

113

2.17

4.43

1.0

—

Pain in joint

2.35

4.41

1.0

1.1

—

Bronchitis

184

1.88

4.37

1.1

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

150

2.20

4.33

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

117

2.26

4.33

1.1

1.0

—

Amputation of toe

6.27

4.29

1.0

—

Explicit bacterial Sepsis

6.26

4.29

1.1

1.0

—

Any reimbursement code in KELA

2.72

4.28

1.0

—

Vasculitis limited to skin, not elsewhere classified

11.74

4.28

1.3

1.0

—

Other disorders of white blood cells

8.92

4.28

1.3

1.0

—

Pneumonia due to other infectious organisms, not elsewhere classified

11.72

4.28

1.3

1.0

—

Chronic nephritic syndrome

11.71

4.27

1.0

—

Vocal cord dysfunction

6.41

4.27

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

165

1.93

4.24

1.1

1.0

—

Seropositive rheumatoid arthritis, strict definition

4.49

4.24

1.1

1.0

—

Periodontitis

171

1.92

4.17

1.0

1.1

—

Other arrhythmias

2.29

4.10

1.0

1.1

—

Endocarditis

8.04

4.06

1.0

—

Other diseases of pericardium

8.03

4.06

1.3

1.0

—

Implicit fungal Sepsis

10.04

4.01

1.0

—

Fungal Sepsis

10.04

4.01

1.0

—

Preparatory care for dialysis

10.04

4.01

1.0

—

COPD, hospital admissions

108

2.27

4.00

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

2.15

3.99

1.0

—

Headache

2.31

3.95

1.1

1.0

—

105

2.36

3.89

1.1

1.0

—

Provisional assignment of new diseases of uncertain etiology

131

2.21

3.89

1.0

—

Seropositive rheumatoid arthritis, wide

2.77

3.84

1.1

1.0

—

Chronic periodontitis, including avohilmo

172

1.87

3.83

1.0

1.1

—

Codes for special purposes

132

2.19

3.83

1.0

—

Chronic sinusitis

107

2.34

3.81

1.1

1.0

—

Other and unspecified vasculitis limited to skin

12.07

3.76

1.3

1.0

—

Systemic lupus erythematosus

12.04

3.76

1.0

—

Dialysis

12.04

3.76

1.0

—

Bacterial intestinal infections, IBD co-morbidities

3.59

3.69

1.0

—

Pain, not elsewhere classified

3.00

3.68

1.0

—

Cerebrovascular diseases

139

1.97

3.67

1.1

—

Later onset COPD

2.61

3.66

1.1

1.0

—

Oedema, not elsewhere classified

2.87

3.63

1.1

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

182

1.81

3.62

1.1

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

135

1.93

3.61

1.0

1.1

—

Early onset COPD, excluding more controls

4.40

3.61

1.2

1.0

—

Other bacterial intestinal infections

3.50

3.60

1.0

1.1

—

COPD related to multimorbidity

2.26

3.59

1.2

1.0

—

Suppurative and necrotic conditions of lower respiratory tract

7.80

3.56

1.0

—

Idiopathic gout

4.77

3.55

1.0

1.1

—

Insulin medication

142

2.01

3.53

1.0

1.1

—

Atrial fibrillation and flutter with reimbursement

3.94

3.52

1.1

1.0

—

Other specified/unspecified arthritis

2.81

3.51

1.2

1.1

—

Olecranon bursitis

6.17

3.50

1.0

1.1

—

Unspecified acute lower respiratory infection

3.88

3.48

1.2

1.0

—

Mycoses

2.61

3.46

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

157

1.98

3.43

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

2.17

3.42

1.1

—

Other diseases of intestines

163

1.78

3.41

1.1

1.0

—

Diseases of liver

2.34

3.40

1.0

1.1

—

Cardiac arrest

7.49

3.38

1.0

1.1

—

Metabolic disorders

154

1.82

3.37

1.0

1.1

—

Other coagulation defects

5.73

3.34

1.0

—

Chronic lower respiratory diseases

177

1.71

3.32

1.1

1.0

—

Syncope and collapse

2.40

3.31

1.1

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.62

3.29

1.1

1.0

—

Other/unspecified seropositive rheumatoid arthritis

2.62

3.29

1.1

1.0

—

Other and unspecified polyneuropathies, also in other diseases

2.92

3.29

1.1

—

Retention of urine

2.35

3.29

1.0

1.1

—

Urticaria and erythema

2.47

3.28

1.1

1.0

—

Abnormal findings on examination of urine, without diagnosis

8.60

3.26

1.3

1.0

—

Arterial embolism and thrombosis of lower extremity artery

8.60

3.26

1.0

—

Persons encountering health services in other circumstances, wide

172

1.71

3.25

1.1

1.0

—

Lung cancer and mesothelioma

3.67

3.24

1.0

—

Agranulocytosis

4.74

3.23

1.0

—

Intestinal infectious diseases

184

1.71

3.22

1.1

1.0

—

Other bacterial intestinal infections

2.67

3.22

1.0

1.1

—

Myocardial infarction, without ST-elevation

105

2.17

3.21

1.0

1.1

—

Disorders of lacrimal system

103

2.23

3.19

1.2

1.0

—

Adjustment and management of implanted device

3.53

3.19

1.0

1.1

—

Diabetic neuropathy

4.15

3.17

1.1

1.0

—

Ischaemic heart disease, wide definition

116

1.92

3.12

1.0

1.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.51

3.11

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

120

2.07

3.08

1.0

1.1

—

Cardiac arrhythmias

2.20

3.07

1.0

—

Other disorders of lacrimal gland

2.33

3.07

1.1

1.0

—

Hypertrophic cardiomyopathy

7.52

3.05

1.2

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

2.68

3.05

1.1

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

5.01

3.05

1.0

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

2.58

3.03

1.1

1.0

—

Covid-19 confirmed case

2.26

3.02

1.0

1.1

—

Persons encountering health services for specific procedures, not carried out

5.84

3.02

1.0

—

Systemic lupus erythematosus, unspecified

10.04

2.98

1.0

—

3.85

2.97

1.2

1.0

—

Type 2 diabetes

150

1.75

2.93

1.0

1.1

—

Idiopathic pulmonary fibrosis

4.72

2.92

1.1

1.0

—

Bronchiectasis

4.71

2.92

1.5

1.0

—

Other (seronegative) rheumatoid arthritis, wide

2.83

2.91

1.1

1.0

—

Arthropathies

118

1.80

2.90

1.1

1.0

—

Other/unspecified dorsalgia

2.25

2.87

1.0

1.1

—

Arterial embolism and thrombosis

5.39

2.86

1.0

1.1

—

Soft tissue disorders related to use, overuse and pressure

2.50

2.86

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

169

1.72

2.84

1.0

1.1

—

Hypertensive heart and/or renal disease

2.67

2.84

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

3.16

2.84

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

119

1.95

2.80

1.1

—

Other infectious diseases

4.45

2.79

1.0

1.1

—

Other and unspecified local infections of skin and subcutaneous tissue

4.45

2.79

1.1

1.0

—

Pacemaker

2.23

2.79

1.1

—

Other viral diseases

2.27

2.78

1.2

1.0

—

Other/unspecified rheumatoid arthritis

3.58

2.78

1.1

1.0

—

Aortic aneurysm

2.64

2.77

1.1

—

Unspecified privation

3.92

2.77

1.0

—

Isolated proteinuria

8.36

2.75

1.4

1.0

—

Allergic purpura

8.36

2.75

1.0

—

SLE, ICD10

8.36

2.75

1.0

—

SLE, strict definition

8.36

2.75

1.0

—

Acute posthaemorrhagic anaemia

8.36

2.75

1.0

—

Abnormalities of heart beat

2.45

2.75

1.0

—

Invasive ventilation

5.01

2.73

1.1

1.0

—

Other infectious diseases

5.01

2.72

1.0

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.36

2.71

1.2

1.0

—

Insulin, intermediate and long-acting

148

1.90

2.71

1.0

1.1

—

Asthma and opportunity respiratory infection

6.02

2.70

1.2

1.0

—

Other and unspecified psoriasis

6.01

2.70

1.2

1.0

—

Other local infections of skin and subcutaneous tissue

4.22

2.67

1.1

1.0

—

Viral pneumonia

3.75

2.67

1.0

—

Symptoms and signs involving the digestive system and abdomen

139

1.69

2.66

1.1

—

Statin medication

1.94

2.65

1.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

2.39

2.62

1.0

1.1

—

Depression medications

3.46

2.60

1.0

1.1

—

Chronic ulcer of skin, not elsewhere classified

4.67

2.59

1.1

1.0

—

Diseases of the respiratory system

2.09

2.59

1.0

—

Symptoms and signs involving the urinary system

155

1.77

2.59

1.0

1.1

—

Nonsuppurative otitis media

2.68

2.58

1.2

1.0

—

Cholelithiasis, broad definition with cholecystitis

151

1.74

2.58

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

147

1.70

2.58

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

137

1.92

2.58

1.0

—

Pure hypercholesterolaemia

127

1.80

2.57

1.0

1.1

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

5.47

2.54

1.2

1.0

—

Other aneurysm

5.47

2.54

1.0

—

Reactive arthropathies, FINNGEN

5.46

2.54

1.0

—

Other viral diseases

2.35

2.53

1.2

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

3.23

2.51

1.0

1.1

—

Type 2 diabetes, definitions combined

146

1.69

2.46

1.0

1.1

—

Nonischemic cardiomyopathy

3.81

2.46

1.1

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.25

2.45

1.0

1.1

—

Coxarthrosis [arthrosis of hip](FG)

2.06

2.43

1.0

—

Type 2 diabetes, strict (exclude DM1)

147

1.68

2.41

1.0

1.1

—

Other diseases of liver

2.90

2.41

1.0

1.1

—

Stroke, including SAH

124

1.81

2.41

1.1

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

3.64

2.36

1.0

—

Hydronephrosis

4.12

2.36

1.0

—

Coronary atherosclerosis

1.86

2.31

1.0

—

Candidiasis

3.22

2.30

1.0

—

Oxycodone

2.10

2.30

1.0

—

Diseases of the musculoskeletal system and connective tissue

2.08

2.29

1.0

—

Right hemicolectomy

4.62

2.27

1.2

1.1

—

Osteonecrosis

4.62

2.27

1.0

—

Osteomyelitis

4.62

2.27

1.0

—

Fitting and adjustment of other devices

2.11

2.22

1.0

1.1

—

Polyarthritis, unspecified

5.57

2.21

1.4

1.0

—

Melanoma in situ

5.57

2.21

1.0

—

Secondary right heart disease

5.57

2.21

1.0

1.1

—

Other pulmonary heart/vessel disease

5.57

2.21

1.0

1.1

—

Other inflammatory liver diseases

5.56

2.21

1.0

—

Thoracic aortic aneurysm

2.86

2.20

1.0

1.1

—

Calcific aortic valvular stenosis, operated

2.14

2.20

1.0

1.1

—

Calcific aortic valvular stenosis

2.14

2.20

1.0

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.14

2.20

1.0

1.1

—

Operations 2 for CAVS

2.14

2.20

1.0

1.1

—

DVT of lower extremities

2.41

2.19

1.1

—

Myocardial infarction, with ST-elevation

2.50

2.18

1.0

1.1

—

Orchitis and epididymitis

3.34

2.18

1.3

1.1

—

Candidiasis

2.24

2.17

1.0

—

Diagnoses used for exclusion with ILD

2.24

2.17

1.0

1.1

—

Unspecified haematuria

1.94

2.16

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

116

1.80

2.15

1.1

1.0

—

Hyperkalaemia

4.29

2.15

1.0

1.1

—

Overexertion and strenuous or repetitive movements

3.69

2.15

1.1

1.0

—

Gingivitis and periodontal diseases

149

1.59

2.14

1.0

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

2.11

2.13

1.0

1.1

—

Biological medication for rheuma

2.78

2.13

1.1

1.0

—

Diabetes mellitus

161

1.60

2.13

1.0

1.1

—

Osteopathies and chondropathies

134

1.81

2.12

1.0

1.1

—

Diabetes, varying definitions

162

1.59

2.11

1.0

1.1

—

Parasetamol

100

1.72

2.10

1.0

—

Sequelae with surgical and medical care as external cause

2.45

2.10

1.0

—

COPD-related respiratory insufficiency

3.20

2.09

1.3

1.0

—

Disorders of thyroid, IBD co-morbidities

3.79

2.09

1.0

—

Hypothyroidism and >3 levothyroxin purchases

3.48

2.07

1.0

1.2

—

Hypothyroidism, levothyroxine purchases

3.48

2.07

1.0

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

172

1.55

2.06

1.1

1.0

—

Coronary artery bypass grafting

2.24

2.05

1.1

—

Insulin, fast-acting

1.98

2.04

1.0

1.1

—

Acne vulgaris

4.00

2.04

1.0

—

Cholelithiasis

151

1.64

2.02

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.53

2.01

1.2

1.1

—

Stroke, excluding SAH

122

1.74

2.00

1.1

1.0

—

Pleural effusion

2.63

2.00

1.1

—

Corneal ulcer

2.63

2.00

1.3

1.0

—

Diabetes medication

167

1.56

1.97

1.0

1.1

—

Other cataract

1.85

1.96

1.1

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

2.09

1.96

1.1

—

Angina pectoris

1.84

1.96

1.0

—

Hypertensive Heart Disease

2.41

1.94

1.0

1.1

—

Other/unspecified reactive arthropathies

4.55

1.94

1.0

—

Etanercept

4.55

1.94

1.2

1.0

—

Hypothyroidism (congenital or acquired)

3.23

1.94

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

179

1.54

1.93

1.1

1.0

—

Hernia of abdominal wall, postoperative

2.73

1.93

1.1

1.0

—

Chronic apical periodontitis

184

1.52

1.93

1.1

1.0

—

Gastrointestinal diseases

1.84

1.92

1.0

—

Acute pharyngitis

2.71

1.91

1.3

1.0

—

Insulin, fast-acting or short human

1.92

1.89

1.0

1.1

—

Disorders of sclera, cornea, iris and ciliary body

143

1.75

1.88

1.1

1.0

—

Other pleural conditions

3.19

1.88

1.1

1.0

—

Otitis externa

2.31

1.87

1.1

1.0

—

Enlarged lymph nodes

2.65

1.86

1.1

—

Abdominal and pelvic pain

139

1.55

1.84

1.1

—

GI-bleeding

1.98

1.84

1.1

—

Polyuria

2.20

1.84

1.0

1.1

—

Erectile dysfunction

3.53

1.83

1.0

—

Psoriatic arthropathies

3.53

1.83

1.2

1.0

—

Dermatographic urticaria

4.17

1.82

1.0

—

Inflammatory diseases of the central nervous system

4.17

1.82

1.0

—

Diseases of the digestive system

122

1.79

1.80

1.1

—

Non-invasive ventilation

2.59

1.79

1.1

1.0

—

Other diseases of the digestive system

1.95

1.79

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

188

1.52

1.76

1.0

1.1

—

Other diseases of biliary tract

3.34

1.74

1.0

1.1

—

Arthropathic psoriasis

3.34

1.74

1.2

1.0

—

Valvular operations

2.50

1.73

1.0

1.1

—

Other (not insulin) diabetes medications

154

1.54

1.73

1.1

—

Disorders of eyelid, lacrimal system and orbit

181

1.55

1.73

1.2

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.86

1.72

1.0

—

Abnormal findings on diagnostic imaging of other body structures

2.67

1.72

1.1

1.0

—

Other keratitis

2.92

1.72

1.3

1.0

—

Decubitus ulcer and pressure area

3.85

1.71

1.2

1.0

—

Injury of other and unspecified intrathoracic organs

3.85

1.71

1.2

1.0

—

Pyogenic arthritis

3.85

1.71

1.0

—

Caries of dentine, including avohilmo

112

1.60

1.70

1.1

—

Non-allergic asthma (mode), excluding more controls

2.89

1.70

1.0

—

Other neurological diseases

152

1.60

1.67

1.0

1.1

—

Tonsillectomy and adenotomy

0.37

1.67

1.0

—

Other functional intestinal disorders

103

1.80

1.66

1.2

1.0

—

Sicca syndrome [Sjögren]

3.16

1.66

1.2

1.0

—

Emphysema

3.16

1.66

1.0

—

Reactive arthropathies

3.16

1.66

1.0

—

Other psoriatic arthropathies

3.16

1.66

1.2

1.0

—

Psoriatic arthropathies, ICD10

3.16

1.66

1.2

1.0

—

Acne

3.16

1.66

1.0

—

Other bursopathies

2.58

1.65

1.0

1.1

—

Migraine without aura

2.58

1.65

1.0

—

Other viral diseases, not elsewhere classified

2.17

1.65

1.0

—

Other inflammation of eyelid

2.80

1.65

1.6

1.0

—

Soft tissue disorders

147

1.51

1.65

1.0

1.1

—

Sciatica+with lumbago

123

1.72

1.64

1.0

1.1

—

Genitourinary diseases

1.77

1.61

1.0

1.1

—

Thrombocytopenia, unspecified

3.58

1.61

1.0

—

Nummular dermatitis

3.58

1.61

1.0

—

Infectious mononucleosis

3.57

1.61

1.2

1.0

—

Spinal stenosis

107

1.70

1.61

1.0

1.1

—

Hyperparathyroidism

2.35

1.60

1.1

1.0

—

Tumor necrosis factor alpha inhibitors

2.50

1.59

1.1

1.0

—

Diverticular disease of intestine

124

1.60

1.59

1.0

—

Biguanides

157

1.51

1.59

1.0

1.1

—

Mycoses

206

1.52

1.59

1.0

1.1

—

Neoplasms

102

1.61

1.59

1.0

—

Zoster [herpes zoster]

2.33

1.58

1.0

—

Nerve, nerve root and plexus disorders

183

1.47

1.58

1.0

1.1

—

Pruritus

3.00

1.58

1.0

1.1

—

Psoriatic and enteropathic arthropathies

3.00

1.58

1.2

1.0

—

Otitis externa, unspecified

3.00

1.58

1.0

—

Abnormalities of gait and mobility

2.69

1.58

1.0

—

Constipation

174

1.51

1.58

1.1

1.0

—

Acute bronchiolitis

3.47

1.55

1.0

—

Superficial injury of hip and thigh

2.42

1.53

1.0

—

Abnormal serum enzyme levels

1.88

1.53

1.0

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

2.24

1.53

1.0

—

Viral pneumonia (unknown virus, not influenza)

3.34

1.52

1.0

—

Melanocytic naevi, other sites/unspecified

3.34

1.52

1.0

—

Bronchitis, not specified as acute or chronic

3.34

1.52

1.0

—

Mucosal proctocolitis

2.59

1.51

1.1

1.0

—

Ulcerative colitis, NAS

2.59

1.51

1.1

1.0

—

Other diseases of hard tissues of teeth

1.64

1.49

1.1

—

Other medical care

1.76

1.48

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

161

1.45

1.46

1.0

—

Chronic laryngitis and laryngotracheitis

2.50

1.45

1.0

—

Alcohol abuse, main dg

2.50

1.45

1.0

—

Other viral diseases, not elsewhere classified

2.36

1.45

1.0

—

Persons encountering health services in other circumstances

1.80

1.44

1.1

1.0

—

Pain (limb, back, neck, head abdominally)

1.60

1.44

1.0

1.1

—

Sequelae of injuries of upper limb

3.13

1.44

1.0

—

Undetermined asthma, excluding more controls

3.12

1.43

1.2

1.0

—

Other CVD (FINNGEN)

3.23

1.43

1.2

1.1

—

Non-allergic asthma (mode)

2.48

1.43

1.0

—

Urticaria

2.03

1.43

1.1

1.0

—

Other disorders of bone

2.31

1.42

1.0

1.1

—

Recurrent aphthous stomatitis , including avohilmo

2.42

1.39

1.0

—

Fall on same level

186

1.41

1.38

1.1

1.0

—

Single delivery by caesarean section

0.00

1.38

0.0

1.0

—

Premature rupture of membranes

0.00

1.38

0.0

1.0

—

Chronic pancreatitis

2.61

1.36

1.0

—

Other diseases of arteries and capillaries

2.94

1.36

1.0

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

2.94

1.36

1.0

—

Transport accidents

102

1.69

1.36

1.2

1.1

—

Neurological diseases, wide definition

2.26

1.34

1.0

—

Other female pelvic inflammatory diseases

0.00

1.34

0.0

1.0

—

Familial hypercholesterolemia

2.14

1.33

1.0

1.1

—

Other and unspecified urticaria

2.14

1.33

1.1

1.0

—

Acute alcohol intoxication, ICD10

2.14

1.33

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

173

1.44

1.32

1.1

1.0

—

Acute upper respiratory infections

187

1.42

1.31

1.1

1.0

—

Migraine without aura and triptan purchases

2.50

1.30

1.0

—

Colectomy operation

2.09

1.30

1.1

1.0

—

COPD, hospital admissions 1, only main diagnosis

1.71

1.29

1.1

—

Cholecystitis

2.35

1.29

1.0

1.1

—

Mental and behavioural disorders due to alcohol

139

1.59

1.29

1.0

1.1

—

Hypothyroidism, strict autoimmune

104

1.58

1.28

1.0

—

Synovial cyst of popliteal space [Baker]

2.78

1.28

1.0

1.1

—

Diabetic maculopathy, excluding more controls

2.78

1.28

1.2

1.1

—

LSIL lesion of the cervix uteri

2.78

1.28

1.0

—

Thyroiditis, ILD-related definition

2.78

1.28

1.0

—

Other disorders of veins

1.73

1.28

1.1

—

Unstable angina pectoris

1.78

1.28

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.96

1.27

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

154

1.45

1.27

1.1

—

Mental and behavioural disorders due to psychoactive substance use

164

1.53

1.27

1.0

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2.29

1.26

1.1

1.0

—

Substance abuse, excluding more controls

137

1.56

1.26

1.0

1.1

—

Familial hypercholesterolemia, with ischemic heart disease

2.40

1.24

1.0

1.1

—

Thiazolidinediones

2.40

1.24

1.0

—

Seronegative rheumatoid arthritis

2.40

1.24

1.0

—

Psoriasis vulgaris

2.22

1.24

1.1

—

All dysplastic lesions of the cervix uteri

2.20

1.23

1.0

—

Spondylopathies

134

1.47

1.23

1.0

1.1

—

Dementia

102

0.47

1.23

1.0

—

Other dorsopathies, not elsewhere classified

156

1.41

1.23

1.0

1.1

—

Coxarthrosis

1.65

1.22

1.1

—

Early onset COPD

1.97

1.22

1.2

1.0

—

Undetermined asthma

2.63

1.21

1.2

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.16

1.21

1.0

—

Somatoform disorder

2.16

1.21

1.1

1.0

—

Disorders of the thyroid gland

169

1.43

1.20

1.0

—

Endocrine, nutritional and metabolic diseases

1.52

1.19

1.1

—

Abrasion of teeth

1.83

1.19

1.0

—

Dermatophytosis

2.31

1.18

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.31

1.18

1.0

—

Other gastritis (incl. Duodenitis)

1.88

1.17

1.0

1.1

—

Status post-ami

1.91

1.17

1.1

—

Diseases of salivary glands

1.77

1.16

1.0

1.1

—

Other abnormal uterine and vaginal bleeding

1.97

1.16

1.0

1.1

—

Use of rivastigmine

0.00

1.15

0.0

1.0

—

Vitreous haemorrhage

2.50

1.15

1.0

—

Asthma, hospital admissions , main diagnosis only

204

1.43

1.14

1.1

1.0

—

Disorders of lens

112

1.50

1.14

1.1

—

Gastroduodenal ulcer

1.80

1.14

1.2

1.1

—

Diabetic retinopathy, excluding more controls

2.08

1.13

1.1

—

Zoster [herpes zoster]

132

1.57

1.13

1.1

1.0

—

Other disorders of bladder

2.34

1.12

1.0

1.1

—

Alcohol abuse, main dg, excluding more controls

2.26

1.10

1.0

—

Papulosquamous disorders

1.67

1.09

1.1

—

Dermatitis

159

1.50

1.09

1.1

—

Benign neoplasm: Transverse colon

2.38

1.09

1.2

1.0

—

Other complications of surgical and medical care, not elsewhere classified

2.38

1.09

1.0

—

Melanocytic naevi of trunk

2.38

1.09

1.0

—

Volume depletion

2.38

1.09

1.0

—

Dental caries, including avohilmo

109

1.45

1.08

1.0

1.1

—

Dorsalgia

155

1.38

1.08

1.0

1.1

—

Convulsions, not elsewhere classified

1.94

1.07

1.2

1.0

—

Asthma, including avohilmo

197

1.34

1.07

1.1

1.0

—

Fracture of lumbar spine and pelvis

1.86

1.06

1.0

—

Persons encountering health services in circumstances related to reproduction

103

0.52

1.06

1.0

—

Asthma (diagnoses ohter than nonallergic)

202

1.40

1.05

1.1

1.0

—

Substance abuse

159

1.48

1.05

1.0

1.1

—

Obesity due to excess calories

113

1.59

1.05

1.1

—

Viral infections characterized by skin and mucous membrane lesions

113

1.59

1.05

1.0

1.1

—

Carcinoma in situ of skin

2.27

1.03

1.0

—

Carcinoma in situ of skin of other and unspecified parts of face

2.27

1.03

1.0

—

Rosacea

2.27

1.03

1.0

—

Disorders of muscles

2.27

1.03

1.0

—

Covid-19 suspected case

1.96

1.03

1.0

—

Keratitis

1.63

1.03

1.2

1.0

—

Disorders of parathyroid gland

1.90

1.02

1.1

1.0

—

Abdominal aortic aneurysm (AAA)

2.25

1.02

1.2

1.0

—

Other symptoms and signs involving cognitive functions and awareness

118

1.54

1.02

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.56

1.01

1.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.89

1.01

1.0

—

Other CVD

1.89

1.01

1.1

—

Obesity, other/unspecified

1.77

1.00

1.1

1.0

—

Spondylosis

119

1.51

1.00

1.0

1.1

—

Aneurysms, operations, SAH

2.00

1.00

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

151

1.42

0.99

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

156

1.45

0.99

1.1

1.0

—

Obesity

158

1.47

0.98

1.1

1.0

—

Pedal cyclist injured in noncollision transport accidents

2.18

0.98

1.2

1.0

—

Bell's palsy

2.17

0.98

1.0

—

Subarachnoid haemorrhage

2.18

0.98

1.0

—

Vitamin B12 deficiency anaemia

2.17

0.98

1.2

1.0

—

Tooth eruption problems

0.00

0.97

0.0

1.0

—

Leiomyoma of uterus

1.55

0.97

1.0

—

Malignant neoplasm, wide definition for exclusion

134

1.40

0.97

1.0

1.1

—

156

1.45

0.96

1.0

1.1

—

Iridocyclitis

1.80

0.96

1.0

—

Erosion of teeth , including avohilmo

1.80

0.96

1.0

—

Cholecystectomy

156

1.44

0.96

1.0

1.1

—

Psoriasis

1.74

0.96

1.1

1.0

—

Medical treatment for female infertility

0.00

0.96

0.0

1.0

—

Other arthrosis

1.55

0.95

1.1

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

175

1.35

0.95

1.1

—

Asthma/COPD (KELA code 203)

176

1.36

0.94

1.1

1.0

—

Fibroblastic disorders

1.77

0.94

1.1

—

Injuries to the head

200

1.32

0.93

1.1

1.0

—

Basal cell carcinoma, including avohilmo

1.54

0.93

1.1

—

Lesion of ulnar nerve

2.22

0.93

1.0

1.1

—

Obesity and other hyperalimentation

160

1.45

0.93

1.1

1.0

—

Melanocytic naevi

1.71

0.92

1.0

—

Congenital malformations of the circulatory system

2.16

0.91

1.0

—

Diabetic retinopathy

1.61

0.91

1.1

1.0

—

Follow-up examination after treatment for malignant neoplasms

2.14

0.91

1.0

1.1

—

Lichen planus

2.14

0.91

1.2

1.0

—

Other metabolic disorders

2.14

0.91

1.0

—

Chondropathies

2.14

0.91

1.0

1.1

—

Low back pain

149

1.40

0.91

1.0

1.1

—

Lower back pain or/and sciatica

197

1.33

0.90

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

208

1.36

0.90

1.1

1.0

—

Presence of other devices

1.74

0.89

1.0

—

Other headache syndromes

104

0.48

0.88

1.0

—

Special screening examination for infectious and parasitic diseases

1.90

0.88

1.1

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.51

0.88

1.1

—

Organic, including symptomatic, mental disorders

121

0.59

0.87

1.0

—

Senile cataract

107

1.43

0.87

1.0

1.1

—

Malignant melanoma, including Hilmo

1.86

0.87

1.0

1.1

—

Noninfectious colitis NAS

2.00

0.87

1.0

—

Acute sinusitis

118

1.49

0.86

1.2

1.0

—

Hyperlipidaemia, other/unspecified

1.55

0.85

1.0

1.1

—

Sequelae of external causes of morbidity and mortality

1.67

0.85

1.0

1.1

—

Other diseases of upper respiratory tract

172

1.30

0.84

1.1

1.0

—

Disorder of lipoprotein metabolism, unspecified

1.94

0.84

1.2

1.1

—

Intracerebral haemorrhage

1.94

0.84

1.0

1.1

—

Palmar fascial fibromatosis [Dupuytren]

1.78

0.84

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

103

1.54

0.83

1.0

1.1

—

Nontoxic multinodular goitre

1.74

0.82

1.0

—

Recurrent or chronic depression

1.57

0.82

1.1

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

184

1.38

0.82

1.1

1.0

—

Misadventures to patients during surgical and medical care

1.88

0.81

1.0

—

Dementia, including avohilmo

104

0.59

0.81

1.0

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.80

0.0

1.0

—

Malignant neoplasm of skin

1.48

0.80

1.1

—

Gastric ulcer

1.70

0.80

1.3

1.1

—

Any event in cancer register

140

1.35

0.80

1.1

—

Chronic diseases of tonsils and adenoids

143

0.66

0.80

1.0

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

0.80

0.0

1.1

—

Polyarthrosis

1.69

0.79

1.0

—

Impacted cerumen

0.00

0.79

0.0

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

1.82

0.79

1.0

1.1

—

Lung diseases due to external agents

1.82

0.79

1.0

1.1

—

Myalgia

1.67

0.78

1.0

—

Injuries to the shoulder and upper arm

201

1.32

0.78

1.0

1.1

—

Flat foot [pes planus] (acquired)

0.00

0.78

0.0

1.0

—

In situ neoplasms

1.53

0.78

1.0

1.1

—

Type 1 diabetes

1.66

0.78

1.0

1.1

—

Dorsopathies

157

1.29

0.76

1.0

1.1

—

Other disorders of the musculoskeletal system and connective tissue

1.77

0.76

1.2

1.0

—

Injury of muscle and tendon at lower leg level

1.77

0.76

1.2

1.0

—

Acute suppurative otitis media

1.71

0.75

1.0

—

Polycystic ovarian syndrome, consortium definition

1.43

0.75

1.0

—

161

1.37

0.74

1.0

1.1

—

Superficial injury of ankle and foot

2.08

0.74

1.0

—

Duodenal ulcer

2.08

0.74

1.0

1.1

—

Pregnancy with abortive outcome

1.45

0.74

1.0

—

Basal cell carcinoma

1.47

0.74

1.1

—

Other joint disorders

118

1.34

0.73

1.0

—

Nontraumatic intracranial haemmorrhage

1.64

0.73

1.0

1.1

—

Anxiety disorders, excluding more controls

141

1.34

0.73

1.1

—

Injuries to the ankle and foot

171

1.35

0.73

1.0

1.1

—

Primary hyperparathyroidism

2.00

0.72

1.0

—

Malignant melanoma

1.80

0.72

1.0

1.1

—

Ulcerative colitis

1.61

0.72

1.1

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

147

1.33

0.72

1.0

1.1

—

Hallux valgus (acquired)

1.60

0.71

1.0

—

Use of pramipexole

1.58

0.71

1.0

1.1

—

Noninflammatory disorders of female genital tract

0.52

0.71

1.0

—

Benign neoplasm: Colon

144

1.39

0.71

1.1

1.0

—

Other/unspecified synovitis and tenosynovitis

1.92

0.70

1.0

1.1

—

Ectopic pregnancy

1.92

0.70

1.0

—

All influenza (not pneumonia)

1.92

0.70

1.0

—

Car occupant injured in other and unspecified transport accidents

1.71

0.70

1.3

1.0

—

Deviated nasal septum

1.50

0.69

1.0

1.1

—

Amiodarone users

1.85

0.68

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.85

0.68

1.0

—

Ovarian cyst

1.56

0.68

1.0

—

Dysphagia

1.64

0.68

1.0

1.1

—

Adverse effects, not elsewhere classified

1.67

0.68

1.0

—

Nausea and vomiting

1.63

0.67

1.1

1.0

—

Stomatitis and related lesions

1.63

0.66

1.0

—

Any mental disorder

163

1.26

0.66

1.0

1.1

—

Ethmoidectomy

1.79

0.66

1.2

1.0

—

5-aminosalicylic acid

1.79

0.66

1.2

1.0

—

Symptoms and signs involving speech and voice

1.51

0.66

1.0

1.1

—

Lichen planus, including avohilmo

1.59

0.65

1.1

1.0

—

Poisoning by medicine

1.59

0.65

1.0

—

Other nutritional deficiencies

169

1.34

0.65

1.1

1.0

—

Chronic gastritis

1.57

0.65

1.1

—

Viral and other specified intestinal infections

1.59

0.65

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.49

0.64

1.1

1.0

—

Use of hypnotics and sedatives

178

1.26

0.64

1.1

—

Restless leg syndrome

1.72

0.64

1.0

—

Other embolism and thrombosis

1.72

0.64

1.0

—

Abnormal involuntary movements

1.72

0.64

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1.55

0.63

1.1

1.0

—

Malignant neoplasm of breast, including Hilmo

1.55

0.63

1.1

1.0

—

Degenerative diseases of the nervous system

0.58

0.63

1.0

1.1

—

Other and unspecified dermatitis

129

1.40

0.63

1.1

—

Other or unspecified ileus, impaction or obstruction

1.63

0.62

1.1

1.0

—

Type 1 diabetes, wide definition, subgroup 1

1.63

0.62

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

103

0.58

0.62

1.2

1.1

—

Other and unspecified effects of external causes

1.59

0.61

1.0

—

Other enthesopathies

1.59

0.61

1.0

—

Caries of enamel

181

1.28

0.61

1.0

1.1

—

Dermatitis and eczema

205

1.24

0.61

1.1

1.0

—

Insulin, fast-acting (human)

1.67

0.61

1.0

1.1

—

Personality disorders, excluding more controls

1.60

0.61

1.0

—

Use of galantamine

0.00

0.60

0.0

1.1

—

Other diseases of oesophagus

0.00

0.60

0.0

1.1

—

Sequelae of cerebrovascular disease

1.44

0.60

1.0

1.1

—

Other skin changes

1.57

0.60

1.0

—

Acute pancreatitis

1.57

0.60

1.0

1.1

—

Acute pancreatitis (for exclusion)

1.57

0.60

1.0

—

Herpesviral [herpes simplex] infections

1.57

0.60

1.0

—

Ménière disease

0.00

0.60

0.0

1.0

—

Diseases of the ear and mastoid process

175

1.23

0.60

1.1

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.59

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.59

0.0

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

1.58

0.59

1.0

1.1

—

Nontoxic goitre/thyroid nodule

1.53

0.59

1.0

—

Superficial injury of lower leg

1.56

0.58

1.0

—

Acute alcohol intoxication

1.56

0.58

1.0

1.1

—

Primary gonarthrosis, bilateral

129

0.66

0.58

1.0

1.1

—

Disease of hard tissues of teeth, NOS

1.36

0.58

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.71

0.57

1.0

—

Dysplasia of cervi uteri

1.48

0.57

1.0

1.1

—

Fracture of skull and facial bones

1.48

0.57

1.0

—

Type 1 diabetes, wide definition

1.48

0.57

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.66

0.56

1.0

—

Disorders of other endocrine glands

113

1.39

0.56

1.1

1.0

—

Any dementia

0.65

0.56

1.0

1.1

—

Personality disorders

1.45

0.56

1.0

—

Deforming dorsopathies

1.54

0.55

1.0

—

Transient ischemic attack

121

1.34

0.55

1.1

1.0

—

Striking against or struck by other objects

1.44

0.55

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

0.58

0.54

1.0

—

Fracture of forearm

138

1.33

0.53

1.0

—

Presence of other functional implants

110

1.32

0.53

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.53

0.52

1.0

1.1

—

Sub-endpoint used in defining T1D endpoints

1.48

0.52

1.0

—

Superficial injury of head

1.52

0.52

1.0

—

Exposure to other specified factors

196

1.26

0.52

1.0

1.1

—

Other obstetric conditions, not elsewhere classified

1.53

0.52

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.52

0.52

1.0

—

Functional dyspepsia

1.43

0.52

1.0

—

Infections with a predominantly sexual mode of transmission

1.43

0.52

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.60

0.52

1.0

—

Long labour

1.51

0.52

1.0

—

Malignant neoplasm of breast, ER-negative, including Hilmo

1.50

0.51

1.2

1.0

—

Complications of labour and delivery

0.68

0.51

1.1

1.0

—

Internal derangement of knee

1.42

0.51

1.0

1.1

—

Other intervertebral disc disorders

144

1.25

0.51

1.0

1.1

—

Injuries to the elbow and forearm

173

1.27

0.50

1.0

1.1

—

Disorders of vitreous body and globe

130

1.33

0.50

1.1

—

Paralytic ileus and intestinal obstruction

1.49

0.49

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

1.30

0.49

1.1

1.0

—

Primary coxarthrosis, bilateral

1.43

0.49

1.0

1.1

—

Viral warts

1.56

0.48

1.0

—

Anterior Iridocyclitis

1.49

0.47

1.0

—

Mood disorders

202

0.80

0.47

1.0

1.1

—

Conductive and sensorineural hearing loss

158

1.24

0.47

1.1

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.31

0.46

1.1

1.0

—

Specific personality disorders

1.46

0.46

1.0

—

Mood [affective] disorders

202

0.80

0.46

1.0

1.1

—

Radiculopathy

1.43

0.46

1.1

—

Disorders of skin appendages

120

1.33

0.45

1.1

1.0

—

Missing teeth due to accident, extraction or parodontitis

155

1.28

0.45

1.0

1.1

—

Gonarthrosis, primary, with knee surgery

140

0.74

0.45

1.1

—

Sensorineural hearing loss

148

1.24

0.44

1.1

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.29

0.44

1.0

—

Poisoning by drugs, medicaments and biological substances

1.37

0.44

1.0

—

Mixed conductive and sensorineural hearing loss

1.61

0.43

1.0

—

Sarcoidosis

1.61

0.43

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

110

1.30

0.42

1.1

1.0

—

Allergic asthma (mode), excluding more controls

1.58

0.42

1.0

—

Disorders of refraction and accommodation

1.42

0.42

1.1

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.56

0.42

1.2

1.0

—

Neurological diseases

128

1.22

0.42

1.0

—

Intestinal stricture

1.38

0.42

1.1

—

Benign neoplasm: Sigmoid colon

1.40

0.42

1.3

1.1

—

Disturbances of skin sensation

1.40

0.42

1.1

1.0

—

Thyrotoxicosis

1.38

0.41

1.0

—

Fracture of foot, except ankle

1.38

0.41

1.0

—

Disorders of adult personality and behaviour

1.38

0.41

1.0

—

Single spontaneous delivery

0.66

0.41

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.27

0.41

1.0

—

Crossbite

0.00

0.41

0.0

1.0

—

Postmenopausal osteoporosis with pathological fracture

0.00

0.41

0.0

1.1

—

Inflammatory disease of cervix uteri

0.00

0.41

0.0

1.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

0.00

0.41

0.0

1.1

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

0.41

0.0

1.0

—

Other obstructed labour

0.00

0.41

0.0

1.0

—

Multiple delivery

0.00

0.41

0.0

1.0

—

Post-traumatic stress disorder

0.00

0.41

0.0

1.0

—

Benign neoplasm of middle ear and respiratory system

0.00

0.41

0.0

1.0

—

Fibromyalgia

0.00

0.41

0.0

1.1

—

Embedded teeth, including avohilmo

0.00

0.41

0.0

1.0

—

Dizziness and giddiness

168

1.23

0.41

1.0

—

Diseases of oral cavity, salivary glands and jaws

1.27

0.41

1.0

1.1

—

Irritable bowel syndrome

1.36

0.41

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.36

0.41

1.1

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.40

0.0

1.0

—

Other diseases of pancreas

0.00

0.40

0.0

1.1

—

Pilonidal cyst

0.00

0.40

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.40

0.0

1.0

—

Early lumbar disc prolapse operation

0.00

0.40

0.0

1.1

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.40

0.0

1.0

—

Benign neoplasm: Ascending colon

1.47

0.40

1.4

1.0

—

Other disorders of conjunctiva

1.47

0.40

1.0

—

Ulcerative colitis (strict definition, require KELA)

1.47

0.40

1.2

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.47

0.40

1.0

—

Pediculosis, acariasis and other infestations

1.47

0.40

1.0

—

Diseases of appendix

195

0.79

0.40

1.0

1.1

—

Other and/or unspecified nontoxic goitre

0.00

0.40

0.0

1.1

—

Deep endometriosis

0.00

0.40

0.0

1.1

—

Abnormalities of forces of labour

0.00

0.40

0.0

1.0

—

Early lumbar disc prolapse, operated

0.00

0.40

0.0

1.1

—

Postpartum haemorrhage due to retained placenta

0.00

0.40

0.0

1.0

—

Coxarthrosis, primary

142

1.25

0.39

1.0

1.1

—

Allergic asthma (mode)

1.44

0.39

1.0

—

Other noninfective gastroenteritis and colitis

1.31

0.39

1.0

—

Certain conditions originating in the perinatal period

0.00

0.39

0.0

1.0

—

Schizophrenia

1.43

0.39

1.0

—

Other diseases of intestine

1.43

0.39

1.2

1.0

—

Chalazion

0.00

0.39

0.0

1.0

—

Sulfonylureas

1.33

0.39

1.0

1.1

—

Other and unspecified tonsillitis

1.38

0.38

1.1

1.0

—

Any dementia, excluding more controls

0.71

0.38

1.0

1.1

—

Other menopausal disorders

1.30

0.37

1.0

1.1

—

Disorders of vitreous body

129

1.27

0.37

1.1

—

Other retinal disorders

146

1.23

0.37

1.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1.35

0.37

1.0

1.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.35

0.37

1.2

1.0

—

Diseases of pulp and periapical tissues and dental caries

100

1.23

0.37

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

0.75

0.36

1.0

—

Voice disturbances

1.29

0.36

1.0

1.1

—

Atopic dermatitis

117

1.26

0.36

1.1

1.0

—

Migraine

1.29

0.36

1.1

1.0

—

Depression

196

0.83

0.35

1.0

1.1

—

Appendicitis, broad definition

192

0.80

0.35

1.0

1.1

—

Disorders of choroid and retina

173

1.19

0.35

1.1

—

Diseases of middle ear and mastoid

132

1.24

0.35

1.1

—

Arthrosis

1.24

0.35

1.0

1.1

—

Suppurative and unspecified otitis media

1.35

0.35

1.0

—

Other blood glucose lowering drugs, excl. Insulins

1.40

0.35

1.0

1.1

—

Adhesive capsulitis of shoulder

1.40

0.35

1.0

1.1

—

Necrosis of pulp, including avohilmo

156

0.77

0.35

1.1

—

Wet age-related macular degeneration

1.39

0.35

1.0

1.1

—

Noninfective enteritis and colitis

126

1.27

0.34

1.1

—

Other disorders of ear

178

1.18

0.34

1.2

1.0

—

Acute and subacute iridocyclitis

1.36

0.34

1.0

—

Nasal polyp

1.36

0.34

1.2

1.0

—

Hypotension

1.36

0.34

1.2

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.34

0.34

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.33

0.34

1.0

—

Thyrotoxicosis, other and/or unspecified

1.33

0.33

1.0

—

Suicide or other Intentional self-harm

1.28

0.32

1.0

—

Other disorders of eyelid

113

1.26

0.32

1.1

1.0

—

Benign neoplasms

156

1.17

0.32

1.1

1.0

—

Psychiatric diseases

151

1.16

0.31

1.0

1.1

—

Extrapyramidal and movement disorders

101

1.29

0.31

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.27

0.31

1.0

—

Haemorrhage in early pregnancy

1.36

0.31

1.0

—

Malignant neoplasm of bronchus and lung

1.32

0.31

1.0

1.1

—

Mood disorders, excluding more controls

157

0.84

0.30

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

140

1.22

0.30

1.0

—

Accidents

119

1.18

0.30

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.29

0.30

1.0

—

Chronic periodontitis, complicated

155

1.21

0.30

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.33

0.30

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.27

0.30

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

169

1.16

0.29

1.0

—

Fracture of shoulder and upper arm

102

1.27

0.29

1.0

—

Gastro-oesophageal reflux disease

159

1.19

0.29

1.1

1.0

—

Female genital prolapse

1.35

0.29

1.0

—

Disorders of breast

0.75

0.29

1.0

—

Gonarthrosis,primary

174

0.85

0.29

1.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.23

0.29

1.1

1.0

—

Meniscus derangement

1.24

0.28

1.0

1.1

—

Hypothyroidism, other/unspecified

158

1.17

0.28

1.0

1.1

—

Disorders of conjunctiva

186

1.16

0.28

1.0

—

Diaphragmatic hernia

1.28

0.28

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

154

1.20

0.28

1.0

1.1

—

Other extrapyramidal and movement disorders in other diseases

1.27

0.27

1.0

1.1

—

Osteoporosis

1.25

0.27

1.0

—

Neurotic, stress-related and somatoform disorders

182

1.15

0.27

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.29

0.27

1.0

—

Anxiety disorders

182

1.15

0.26

1.1

—

Pregnancy, childbirth and the puerperium

1.24

0.26

1.0

—

Viral and other specified intestinal infections

1.19

0.26

1.0

—

Fracture of rib(s), sternum and thoracic spine

1.30

0.26

1.3

1.1

—

L02BG Aromatase inhibitors

0.69

0.26

1.0

—

Malignant neoplasm of breast, HER2-negative

1.31

0.25

1.0

—

Anxiety (asthma-related co-morbidities)

116

1.20

0.25

1.1

1.0

—

Hernia of abdominal wall

127

0.79

0.25

1.1

—

Malignant neoplasm of breast

1.30

0.25

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

1.20

0.25

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.20

0.25

1.1

—

Mouth breathing

114

1.23

0.24

1.1

—

Malignant neoplasm of prostate, including Hilmo

1.28

0.24

1.1

—

Benign lipomatous neoplasm

1.18

0.24

1.0

1.1

—

Malignant neoplasm

133

1.16

0.24

1.0

1.1

—

Other diseases of anus and rectum

1.18

0.24

1.2

1.0

—

Primary open-angle glaucoma, strict

1.18

0.24

1.2

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

123

1.21

0.24

1.0

1.1

—

Diseases of male genital organs

0.83

0.24

1.1

—

Rotator cuff syndrome

115

1.19

0.24

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

156

0.83

0.24

1.0

1.1

—

Diabetic maculopathy

1.35

0.23

1.2

1.0

—

Delivery, wide proxy

0.74

0.23

1.0

—

Falls/tendency to fall

165

1.12

0.23

1.1

1.0

—

Other hammer toe(s) (acquired)

1.28

0.23

1.0

—

Use of levodopa decarboxylase inhibitor

1.28

0.23

1.0

1.1

—

Parkinson's disease, strict definition

1.28

0.23

1.0

1.1

—

Kela-code for severe mental illness

0.74

0.22

1.0

—

Propionic acid derivatives

0.77

0.22

1.0

—

Diseases of inner ear

139

1.18

0.22

1.0

1.1

—

Parkinson's disease, strict definition, excluding more controls

1.22

0.22

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

1.25

0.22

1.0

—

Substance use, excluding alcohol

1.22

0.22

1.0

—

Delivery

0.75

0.22

1.0

—

Traumatic subdural haemorrhage

1.20

0.21

1.2

1.1

—

Parkinson's disease

1.19

0.21

1.0

1.1

—

Leisure time condition

1.19

0.21

1.0

—

Spondylolisthesis/Spondylolysis

1.19

0.21

1.0

—

Bipolar affective disorders

1.19

0.21

1.0

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.21

0.0

1.1

—

Other disorders starting during childhood or adolescence

0.00

0.21

0.0

1.0

—

Mental retardation

0.00

0.21

0.0

1.0

—

Mental retardation, wide definition

0.00

0.21

0.0

1.0

—

Dementia due to Parkinsons disease, excluding more controls

0.00

0.21

0.0

1.1

—

Secondary parkinsonism, excluding more controls

0.00

0.21

0.0

1.1

—

Erosion and ectropion of cervix uteri

0.00

0.21

0.0

1.0

—

Benign neoplasm: Small intestine

0.00

0.21

0.0

1.0

—

Oligomenorrhoea

0.00

0.21

0.0

1.1

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.21

0.0

1.1

—

Malignant neoplasm, without specification of site, including Hilmo

0.00

0.21

0.0

1.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

0.00

0.21

0.0

1.1

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.21

0.0

1.0

—

Calculus of lower urinary tract

0.00

0.21

0.0

1.0

—

Impotence

0.00

0.21

0.0

1.0

—

Dermatitis due to substances taken internally

0.00

0.21

0.0

1.0

—

Lesion of plantar nerve

0.00

0.21

0.0

1.0

—

Nonspecific lymphadenitis

0.00

0.21

0.0

1.0

—

Ulcerative proctitis

0.00

0.21

0.0

1.0

—

Cholangitis (primary sclerosing, PSC)

0.00

0.21

0.0

1.0

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.21

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Neutrophil cytoplasmic Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS